Vitiello P - Search Results

1

Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir.

Bonfanti P, Madeddu G, Gulminetti R, Squillace N, Orofino G, Vitiello P, Rusconi S, Celesia BM, Maggi P, Ricci E; CISAI Study group. Bonfanti P, et al. Among authors: vitiello p. AIDS. 2017 Jan 28;31(3):455-457. doi: 10.1097/QAD.0000000000001351. AIDS. 2017. PMID: 28079544 No abstract available.

2

Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.

De Socio GV, Martinelli C, Ricci E, Orofino G, Valsecchi L, Vitiello P, Martinelli L, Quirino T, Maggi P, Bonfanti P; HERMES study group. De Socio GV, et al. Among authors: vitiello p. Int J STD AIDS. 2010 Apr;21(4):267-72. doi: 10.1258/ijsa.2009.009165. Int J STD AIDS. 2010. PMID: 20378899

3

Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience.

Vitiello P, Taramasso L, Ricci E, Maggi P, Martinelli C, Gabrielli C, Vittorio De Socio G, Di Cristo V, Rusconi S, Falasca K, Menzaghi B, Tebini A, Di Biagio A. Vitiello P, et al. J Women Aging. 2019 Mar-Apr;31(2):176-188. doi: 10.1080/08952841.2018.1428100. Epub 2018 Jan 25. J Women Aging. 2019. PMID: 29369016

4

Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study.

Bonfanti P, De Socio GL, Marconi P, Franzetti M, Martinelli C, Vichi F, Penco G, Madeddu G, Orofino G, Valsecchi L, Vitiello P, Menzaghi B, Magni C, Ricci E. Bonfanti P, et al. Among authors: vitiello p. Curr HIV Res. 2010 Mar;8(2):165-71. doi: 10.2174/157016210790442731. Curr HIV Res. 2010. PMID: 20163341

5

96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation.

Di Cristo V, Adorni F, Maserati R, Annovazzi Lodi M, Bruno G, Maggi P, Volpe A, Vitiello P, Abeli C, Bonora S, Ferrara M, Cossu MV, Oreni ML, Colella E, Rusconi S. Di Cristo V, et al. Among authors: vitiello p. HIV Res Clin Pract. 2020 Feb;21(1):34-43. doi: 10.1080/25787489.2020.1734752. Epub 2020 Mar 4. HIV Res Clin Pract. 2020. PMID: 32129161 Clinical Trial.

6

Negative influence of HIV infection on day-night blood pressure variability.

De Socio GV, Bonfanti P, Martinelli C, Ricci E, Pucci G, Marinoni M, Vitiello P, Menzaghi B, Rizzardini G, Schillaci G. De Socio GV, et al. Among authors: vitiello p. J Acquir Immune Defic Syndr. 2010 Nov;55(3):356-60. doi: 10.1097/QAI.0b013e3181e46456. J Acquir Immune Defic Syndr. 2010. PMID: 20562709

7

Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.

Rusconi S, Vitiello P, Adorni F, Colella E, Focà E, Capetti A, Meraviglia P, Abeli C, Bonora S, D'Annunzio M, Di Biagio A, Di Pietro M, Butini L, Orofino G, Colafigli M, d'Ettorre G, Francisci D, Parruti G, Soria A, Buonomini AR, Tommasi C, Mosti S, Bai F, Di Nardo Stuppino S, Morosi M, Montano M, Tau P, Merlini E, Marchetti G. Rusconi S, et al. Among authors: vitiello p. PLoS One. 2013 Nov 14;8(11):e80157. doi: 10.1371/journal.pone.0080157. eCollection 2013. PLoS One. 2013. PMID: 24244635 Free PMC article. Clinical Trial.

8

Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results.

Ortu M, Vitiello P, Adorni F, Rossotti R, Di Vincenzo P, Vigano O, Galli M, Rusconi S. Ortu M, et al. Among authors: vitiello p. Curr HIV Res. 2011 Dec 1;9(8):625-9. doi: 10.2174/157016211798998790. Curr HIV Res. 2011. PMID: 22211659 Free article.

9

Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.

Vergani B, Cicero ML, Vigano' O, Sirianni F, Ferramosca S, Vitiello P, Di Vincenzo P, Pia De Pasquale M, Galli M, Rusconi S. Vergani B, et al. Among authors: vitiello p. J Clin Virol. 2008 Feb;41(2):154-9. doi: 10.1016/j.jcv.2007.10.003. Epub 2007 Nov 19. J Clin Virol. 2008. PMID: 18024202 Free article.

10

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Mocroft A, et al. PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar. PLoS Med. 2015. PMID: 25826420 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page